Vial of unapproved peptide retatrutide had double the strength indicated on label
Doctors have warned of an “enormous” risk of overdose after testing of a popular unapproved weight loss peptide revealed the product had double the strength of what was listed on its label. A boom in the use of unapproved peptides has been driven by social media influencers promoting their supposed health and beauty benefits, despite…